| 注册
首页|期刊导航|癌症生物学与医学(英文版)|Advances in strategies to improve the immunotherapeutic efficacy of chimeric antigen receptor-T cell therapy for lymphoma

Advances in strategies to improve the immunotherapeutic efficacy of chimeric antigen receptor-T cell therapy for lymphoma

Tianshu Yu Xianhuo Wang Ou Bai Huilai Zhang Wenbin Qian

癌症生物学与医学(英文版)2025,Vol.22Issue(4):301-321,21.
癌症生物学与医学(英文版)2025,Vol.22Issue(4):301-321,21.DOI:10.20892/j.issn.2095-3941.2024.0538

Advances in strategies to improve the immunotherapeutic efficacy of chimeric antigen receptor-T cell therapy for lymphoma

Advances in strategies to improve the immunotherapeutic efficacy of chimeric antigen receptor-T cell therapy for lymphoma

Tianshu Yu 1Xianhuo Wang 2Ou Bai 3Huilai Zhang 2Wenbin Qian1

作者信息

  • 1. Department of Hematology,the Second Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310009,China||Key Laboratory of Cancer Prevention and Intervention,China National Ministry of Education,Key Laboratory of Molecular Biology in Medical Sciences,the Second Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310009,China
  • 2. Department of Lymphoma/State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine,Tianjin Medical University Cancer Institute&Hospital,National Clinical Research Center for Cancer,Tianjin's Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,the Sino-US Center for Lymphoma and Leukemia Research,Tianjin 300060,China
  • 3. Department of Hematology,the First Hospital of Jilin University,Changchun 130015,China
  • 折叠

摘要

关键词

Chimeric antigen receptor-T cell/lymphoma/cytotherapy/immunotherapy/epigenetics/metabolism

Key words

Chimeric antigen receptor-T cell/lymphoma/cytotherapy/immunotherapy/epigenetics/metabolism

引用本文复制引用

Tianshu Yu,Xianhuo Wang,Ou Bai,Huilai Zhang,Wenbin Qian..Advances in strategies to improve the immunotherapeutic efficacy of chimeric antigen receptor-T cell therapy for lymphoma[J].癌症生物学与医学(英文版),2025,22(4):301-321,21.

基金项目

This work was supported by grants from the Science Technology Department of Zhejiang Province(Grant No.2021C03117),Noncommunicable Chronic Diseases-National Science and Technology Major Project(Grant No.2023ZD0501300),National Natural Science Foundation of China(Grant No.82170219),and Zhejiang Provincial Natural Science Foundation of China(Grant No.LQ24H080009). (Grant No.2021C03117)

癌症生物学与医学(英文版)

2095-3941

访问量0
|
下载量0
段落导航相关论文